1 | Study | 1.54% | |
2 | New | 1.08% | |
3 | Health | 1.02% | |
4 | Cancer | 0.91% | |
5 | Risk | 0.89% | |
6 | Disease | 0.78% | |
7 | Patients | 0.78% | |
8 | Treatment | 0.54% | |
9 | May | 0.5% | |
10 | HIV | 0.48% | |
11 | AI | 0.43% | |
12 | Linked | 0.41% | |
13 | Liver | 0.41% | |
14 | Chronic | 0.39% | |
15 | Case | 0.39% | |
16 | Report | 0.39% | |
17 | Brain | 0.37% | |
18 | Alzheimer’s | 0.37% | |
19 | Diabetes | 0.37% | |
20 | Blood | 0.35% | |
21 | Type | 0.35% | |
22 | Therapy | 0.35% | |
23 | According | 0.32% | |
24 | Clinical | 0.32% | |
25 | Researchers | 0.3% | |
26 | Heart | 0.3% | |
27 | Global | 0.3% | |
28 | Diet | 0.28% | |
29 | Research | 0.28% | |
30 | Use | 0.28% | |
31 | Potential | 0.26% | |
32 | Patient | 0.26% | |
33 | Times | 0.26% | |
34 | Drug | 0.26% | |
35 | Hindustan | 0.24% | |
36 | Africa | 0.24% | |
37 | Fatty | 0.24% | |
38 | Data | 0.22% | |
39 | Cell | 0.22% | |
40 | Key | 0.22% | |
41 | Day | 0.22% | |
42 | Obesity | 0.22% | |
43 | Outcomes | 0.22% | |
44 | GLP-1 | 0.19% | |
45 | Impact | 0.19% | |
46 | Early | 0.19% | |
47 | Weight | 0.19% | |
48 | Management | 0.19% | |
49 | Help | 0.19% | |
50 | Drugs | 0.19% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
GLP-1 Drugs Like Semaglutide Gain Attention for Weight Loss and Potential Cardiovascular Benefits
geneonline.com
2025-06-18 10:07:52
Semaglutide Lowers Risk of Kidney Disease Events in Patients With Type 2 Diabetes, CKD
Drug Topics
2025-06-18 05:06:15
Semaglutide More Effective Than Empagliflozin at Lowering Cardiovascular Risks
Managed Healthcare Executive
2025-06-17 06:04:03
GLP-1 Drugs Like Semaglutide Gain Traction in Obesity Management and Global Demand Rises
geneonline.com
2025-06-17 05:06:25